Pneumolabs initially focused on the area of respiratory diseases, and as such, we have a wealth of expertise within this field as well as a bank of relevant models, which we are continuously updating. As we continue to grow and evolve to meet the ever changing needs of our client base, we have broadened our services to encompass other inflammatory diseases.
Inflammatory diseases are increasing in prevalence globally, affecting millions of people by causing pain, disability, disfigurement and death. Patients often remain symptomatic for many years despite using the best available treatments.
At Pneumolabs, our mission is to address this unmet medical need by providing high quality contract research services to progress drug candidates from hit identification through to lead optimisation.